Brain Tumour Ireland is proud to part fund Ireland’s first dedicated brain tumour biobank in partnership with the Royal College of Surgeons in Ireland and Beaumont Hospital.

A biobank is a large collection of biological, medical data and tissue samples, collected for research and diagnostic purposes. A patient who is having brain surgery as part of their clinical treatment will have the tumour removed, examined and diagnosed. After this the excess brain tumour tissue will be stored in the biobank.

Based in Beaumont Hospital, the brain tumour biobank is a repository for brain tumour samples which will enable researchers use samples for future clinical studies, to identify and diagnose tumours in other patients and help develop cancer treatments. All samples included in the biobank are anonymised and patients consent is sought in advance of treatment.

This is the first biobank of its type in Ireland and one of only a small handful that exist in Europe.

In an exciting development the biobank is now supporting a major new study on glioblastoma (GBM). Professor Annette Byrne from RCSI is leading an international team of scientists on a major research study that aims to train the next generation of brain cancer researchers.

The project (“GLIOTRAIN”) has received funding of almost €3.9 million from the European Commission’s Horizon 2020 Research and Innovation Framework Programme.

Brain Tumour Ireland is delighted that the brain tumour biobank which we are part funding, will support this study. It is a really important development in brain tumour research here in Ireland and for the future development of novel therapeutics. We look forward to continued partnership with RCSI and Beaumont Hospital on this fantastic initiative.

The existence of the biobank is of course thanks to the many people who donate to Brain Tumour Ireland and who organise fundraising events for us.

Together we are working to improve outcomes for brain tumour patients and we thank you for your support.